Mersana Therapeutics officer Timothy Lowinger sells $4,667 in stock
In recent transactions disclosed by Mersana Therapeutics, Inc. (NASDAQ:MRSN), Timothy B. Lowinger, the company's Senior Vice ...
Mersana Therapeutics' chief accounting officer sells shares worth $2,061
On January 15, Ashish Mandelia, Vice President and Chief Accounting Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company with a market capitalization of $76 ...